Research on the Effects of High Fructose Corn Syrup on the Fatty Liver Disease and Cardiovascular Disease

Keling Liu

doi:10.54254/2753-8818/2024.19808

Research Article

Open access

Published on 9 January 2025

Download pdf

Liu,K. (2025). Research on the Effects of High Fructose Corn Syrup on the Fatty Liver Disease and Cardiovascular Disease. Theoretical and Natural Science,76,43-49.

Export citation

Research on the Effects of High Fructose Corn Syrup on the Fatty Liver Disease and Cardiovascular Disease

Keling Liu *^,1,

¹ 1.Chiang Mai University, 239 Huay Kaew Rd, Suthep, Mueang Chiang Mai District, Chiang Mai, Thailand; 2. International College of Digital Innovation, Chiang Mai University

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-8818/2024.19808

Abstract

Excessive intake of added sugars and fructose has been associated with leading to adverse health outcomes. This article reviews the effects of sugar intake in a variety of ways, categorized as increased body weight fat, fatty liver (NAFLD), and cardiovascular-related diseases in humans. The analysis showed that decreasing consumption of sugar and sugar products significantly reduced weight, whereas increasing consumption of sugar and sugar products, especially from sugary beverages, led to weight gain. In addition, excessive intake of high sugar is associated with the accumulation of liver fat, a key factor contributing to the increased incidence of fatty liver. The findings highlight the key role of fructose, especially from high fructose corn syrup, in promoting metabolic dysfunction. In conclusion, reducing intake of added sugars is critical to preventing chronic disease and improving public health. Subsequent studies should explore individual differences in response to sugar metabolism and the long-term effects of interventions for small intakes of sugar.

Keywords

Body weight, Fatty liver disease (NAFLD), Cardiovascular disease (CVD), High fructose corn syrup (HFCS)

View pdf

References

[1]. George A. Bray, Barry M. Popkin; Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes?: Health Be Damned! Pour on the Sugar. Diabetes Care 1 April 2014; 37 (4): 950–956

[2]. Taubes G. Good Calories, Bad Calories. New York city, Knopf, 2007

[3]. Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 2012;346:e7492

[4]. Siervo M, Montagnese C, Mathers JC, Soroka KR, Stephan BC, Wells JC. Sugar consumption and global prevalence of obesity and hypertension: an ecological analysis. Public Health Nutrition. 2014;17(3):587-596. doi:10.1017/S1368980013000141

[5]. Basu S, McKee M, Galea G, Stuckler D. Relationship of soft drink consumption to global overweight, obesity, and diabetes: a cross-national analysis of 75 countries. Am J Public Health 2013;103:2071–2077

[6]. Nielsen SJ, Siega-Riz AM, Popkin BM. Trends in food locations and sources among adolescents and young adults. Prev Med 2002;35:107–113

[7]. Putnam J, Allshouse J. Trends in U.S. Per Capita Consumption of Dairy Products, 1909 to 2001. Amber Waves 2003:12–13

[8]. Popkin BM. Patterns of beverage use across the lifecycle. Physiol Behav 2010;100:4–9

[9]. Ng SW, Slining MM, Popkin BM. Use of caloric and noncaloric sweeteners in US consumer packaged foods, 2005-2009. J Acad Nutr Diet 2012;112:1828–1834.e1–6

[10]. Sievenpiper JL, de Souza RJ, Mirrahimi A, et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 2012;156:291–304

[11]. Sievenpiper JL, de Souza RJ, Mirrahimi A, et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 2012;156:291–304

[12]. Cohen JC, Schall R. Reassessing the effects of simple carbohydrates on the serum triglyceride responses to fat meals. Am J Clin Nutr 1988;48:1031–1034

[13]. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010;299:E685–E694

[14]. Cohen JC, Schall R. Reassessing the effects of simple carbohydrates on the serum triglyceride responses to fat meals. Am J Clin Nutr 1988;48:1031–1034

[15]. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322–1334

[16]. Stanhope KL, Bremer AA, Medici V, et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab 2011;96:E1596–E1605

[17]. Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 2009;139:1228S–1235S

[18]. Stanhope KL, Havel PJ. Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans. J Nutr 2009;139:1236S–1241S

[19]. Mattes RD. Dietary compensation by humans for supplemental energy provided as ethanol or carbohydrate in fluids. Physiol Behav 1996;59:179–187

[20]. Maersk M, Belza A, Stødkilde-Jørgensen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 2012;95:283–289

[21]. Raben A, Vasilaras TH, Møller AC, Astrup A. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 2002;76:721–729

[22]. Stanhope KL, Havel PJ. Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans. J Nutr 2009;139:1236S–1241S

[23]. Popkin BM. Patterns of beverage use across the lifecycle. Physiol Behav 2010;100:4–9

[24]. Duffey KJ, Popkin BM. High-fructose corn syrup: is this what’s for dinner? Am J Clin Nutr 2008;88:1722S–1732S

[25]. Duffey KJ, Popkin BM. Shifts in patterns and consumption of beverages between 1965 and 2002. Obesity (Silver Spring) 2007;15:2739–2747

[26]. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004;79:537–543

[27]. Welsh JA, Sharma A, Abramson JL, Vaccarino V, Gillespie C, Vos MB. Caloric sweetener consumption and dyslipidemia among US adults. JAMA 2010;303:1490–1497

[28]. Bray GA. Energy and fructose from sugar sweetened beverages post a health risk for some people. Adv Nutr 2013;220–225

[29]. Aeberli I, Gerber PA, Hochuli M, et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr 2011;94:479–485

[30]. Aeberli I, Hochuli M, Gerber PA, et al. Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial. Diabetes Care 2013;36:150–156

[31]. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010;299:E685–E694

[32]. Bray GA. Potential health risks from beverages containing fructose found in sugar or high-fructose corn syrup. Diabetes Care 2013;36:11–12

Cite this article

Liu,K. (2025). Research on the Effects of High Fructose Corn Syrup on the Fatty Liver Disease and Cardiovascular Disease. Theoretical and Natural Science,76,43-49.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science

Conference website: https://2024.icbiomed.org/

ISBN：978-1-83558-857-4(Print) / 978-1-83558-858-1(Online)

Conference date: 25 October 2024

Editor：Alan Wang

Series: Theoretical and Natural Science

Volume number: Vol.76

ISSN：2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).